Cargando…
Engineered Aptamers for Enhanced COVID-19 Theranostics
INTRODUCTION: The 2019-novel coronavirus disease (COVID-19) is an intractable global health challenge resulting in an aberrant rate of morbidity and mortality worldwide. The mode of entry for SARS-CoV-2 into host cells occurs through clathrin-mediated endocytosis. As part of the efforts to mitigate...
Autores principales: | Acquah, Caleb, Jeevanandam, Jaison, Tan, Kei Xian, Danquah, Michael K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7810429/ https://www.ncbi.nlm.nih.gov/pubmed/33488836 http://dx.doi.org/10.1007/s12195-020-00664-7 |
Ejemplares similares
-
Development of Janus Particles as Potential Drug Delivery Systems for Diabetes Treatment and Antimicrobial Applications
por: Tan, Kei Xian, et al.
Publicado: (2023) -
Target-Specific Delivery and Bioavailability of Pharmaceuticals via Janus and Dendrimer Particles
por: Jeevanandam, Jaison, et al.
Publicado: (2023) -
Synthesis approach-dependent antiviral properties of silver nanoparticles and nanocomposites
por: Jeevanandam, Jaison, et al.
Publicado: (2022) -
Editorial to the IJMS Special Issue “Aptamer-Mediated Cancer Theranostics”
por: Danquah, Michael K.
Publicado: (2023) -
Aptamer-engineered (nano)materials for theranostic applications
por: Rabiee, Navid, et al.
Publicado: (2023)